Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central nervous process, conolidine modulates alternate molecular targets. A Science Advancements analyze discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://michaelk258roj7.wikifrontier.com/user